FILE:COV/COV-8K-20121126161520.txt.gz
EVENTS:	Results of Operations and Financial Condition	Financial Statements and Exhibits
TEXT:
ITEM: Results of Operations and Financial Condition
ITEM: Financial Statements and Exhibits
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
 
FORM 8-K
 
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities and Exchange Act of 1934
Date of Report (Date of earliest event reported): November 26, 2012
 
 
COVIDIEN PUBLIC LIMITED COMPANY
(Exact Name of Registrant as Specified in Charter)
 
 
 
20 On Hatch, Lower Hatch Street
Dublin 2, Ireland
(Address of Principal Executive Offices, including Zip Code)
+353 (1) 438-1700
(Registrant's telephone number, including area code)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 
 
 
 
 
 
 
On December 15, 2011, Covidien plc announced that it plans to spin off its pharmaceuticals business into a standalone public company and made available a presentation that included certain non-public financial information about fiscal 2011. In order to assist investors, the Company has posted to its website an updated version of the presentation that includes certain non-public financial information about fiscal 2012, some of which may be considered material.  
A copy of the presentation material is furnished as Exhibit 99.1 to this report.
(d)    Exhibits
99.1    Investor Presentation
 
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date: November 26, 2012
EXHIBIT INDEX



